MAPK1 and nonpapillary renal cell carcinoma: Moreover, phosphorylation status of two constitutively active survival pathways in ccRCC, PI3K/Akt and MAPK/ERK, which potentiate cell growth, proliferation and invasion in cancer, were also studied [6].